Search

everythinglearnresearchcommunity

for

Search:↓

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Baricitinib is a promising treatment for alopecia areata.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Tofacitinib treatment for hair loss may worsen acne.

A woman with severe hair loss was successfully treated with the drug adalimumab.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Baricitinib was effective in treating alopecia areata in two major trials.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Topical tofacitinib is effective and safe for treating alopecia areata.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.